Navigation Links
Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne
Date:1/6/2009

vision head of dermatology at Henry Ford Hospital in Detroit. "Both adapalene and benzoyl peroxide have extensive histories of efficacy in treating acne, and the data demonstrates that Epiduo(TM) Gel has an even more powerful treatment effect than either monotherapy without compromising tolerability."

A 517-patient Phase 2 trial of Epiduo(TM) Gel published last year in the Journal of the American Academy of Dermatology demonstrates that Epiduo(TM) Gel reduced the median number of total acne lesions by more than 50 percent at the end of the 12-week study, which was significantly better than monotherapy with either adapalene (35.4 percent median reduction in total lesion count) or benzoyl peroxide (35.6 percent median reduction in total lesion count) alone. In addition, the Epiduo(TM) Gel combination therapy worked quickly, with some patients showing improvements after one week of therapy.

A long-term safety and efficacy assessment of Epiduo(TM) Gel published last year in the Journal of Drugs in Dermatology showed that discontinuation of the medication due to adverse events was low - occurring in only 2 percent of all patients. Additionally, none of the 452 patients withdrew from the study as a result of a lack of efficacy.

These studies also showed that Epiduo(TM) Gel is well-tolerated, and rates of side effects were low in all Epiduo(TM) Gel groups. Clinical trials have demonstrated that Epiduo(TM) Gel is well-tolerated from week 1 to week 52, with the majority of patients experiencing low levels of skin irritation associated with the drug.

"The recent FDA approval and upcoming availability of Epiduo(TM) Gel are examples of Galderma's strong research and development capabilities and our ongoing commitment to providing innovative treatment options to patients," said Albert Draaijer, President, Americas, Galderma Laboratories, L.P. "As an industry leader in the dermatology space, our g
'/>"/>

SOURCE Galderma Laboratories
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Galderma Associates Itself to Cartiers Womens Initiative Awards to Recognize Female Entrepreneurs From Around the Globe
2. Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
3. Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
4. ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic
5. Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals
6. Galderma Completes Tender Offer for CollaGenex
7. Galderma announces approval for Differin gel 0.1 percent in Japan
8. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
9. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
10. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
11. HEI, Inc. Announces Sale of RFID Division Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... time to deploy Ebola vaccines is now, Free ... now, according to a commentary being published early online ... . The authors from Yale School of Public Health ... of the current Ebola outbreak represent a public health ... efforts. Several Ebola vaccines have been developed in the ...
(Date:8/20/2014)... Barbara Bronson Gray ... -- Although it,s extremely rare, colds, flu and other ... elevated risk for stroke in children, a new study suggests. ... a stroke in the United States, said Dr. Heather Fullerton, ... and pediatrics at the University of California, San Francisco Benioff ...
(Date:8/20/2014)... Steven Reinberg HealthDay ... The speed at which cancer cells grow may help doctors ... Using this measure, investigators have found that the deadliest ... of older men with a long history of sun exposure. ... the researchers discovered. Rapid cell growth -- called ...
(Date:8/20/2014)... 2014 Park Cities Pet Sitter , ... 4 Pets supply donation drive that benefits the animal shelter ... campaign that coincides with the Humane Society of the United ... through 8th, 2014. , As part of their participation, Park ... monetary donations for the Presents 4 Pets drive from their ...
(Date:8/20/2014)... to spawning grounds through fast-moving waters may be at ... scientists. , When salmon encounter turbulent, fast-moving water ... they must move upstream using a behaviour known as ... , "Days after sockeye passed through extremely fast-moving water, ... distance from their spawning grounds," said Nicholas Burnett, a ...
Breaking Medicine News(10 mins):Health News:News from Annals of Internal Medicine 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 3Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 2Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 3Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 2Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 3Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 4Health News:Salmon forced to 'sprint' less likely to survive migration 2
... of Sciences Leopoldina honored ASU Foundation Professor Bert ... part of the opening ceremonies of the Leopoldina,s ... Hlldobler is highly-regarded, internationally-recognized behavioral scientist ... organization in insects. Ants in particular have served ...
... to perform everyday activities. This is not primarily due to ... was previously believed new research from the University of ... initiate and complete a task towards a specific goal. ... normally results in a degree of paralysis in the lower ...
... A team of researchers from Boston University,s School of ... awarded a five-year, $4.8 million National Institutes of Health ... platform. Based on technologies developed with seed funding ... should be capable of rapidly detecting - at the ...
... high-risk non-melanoma skin carcinomas of the head and neck ... a UNC-led study. Their study is the first to ... simultaneously with radio-and chemotherapy. Scientists with the UNC ... Sept. 26, 2011 online issue of the International ...
... -- The use of long-distance video and data hookups to ... provides the same level of care as having everyone in ... at the Canadian Stroke Congress. The study found that ... Telestroke received an important stroke drug, tPA, at the same ...
... By Serena Gordon HealthDay Reporter , MONDAY, ... linked to the sexually transmitted human papillomavirus (HPV) rose dramatically ... Within a decade, these types of tumors might become the ... the period between 1984 and 1989, just 16.3 percent of ...
Cached Medicine News:Health News:Cothenius Medal awarded to Arizona State University social insect scientist for life's work 2Health News:Cothenius Medal awarded to Arizona State University social insect scientist for life's work 3Health News:Cothenius Medal awarded to Arizona State University social insect scientist for life's work 4Health News:Children with spina bifida need personal 'starter' 2Health News:Researchers from Boston University receive grant to develop improved virus detection system 2Health News:Combination therapy beneficial for head and neck skin carcinomas, UNC study shows 2Health News:Telestroke the next best thing 2Health News:HPV-Linked Oral Cancers on the Rise, Study Finds 2Health News:HPV-Linked Oral Cancers on the Rise, Study Finds 3
(Date:8/20/2014)... Research and Markets has ... Market (Technology, Types, Applications, Services and Geography) - ... their offering. A new report ... - Size, Share, Global Trends, Company Profiles, Demand, ... 2013 - 2020", suggests that the global biosimilars ...
(Date:8/20/2014)... 20, 2014 Research and Markets  has announced ... report to their offering. Global Market ... on Pralmorelin globally and regionally ( Europe , ... , Latin America etc.). It captures ... This report focuses on three primary areas; manufacture methods & ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com announces ... in its catalogue: Global Coatings for ... This report analyzes the ... US$ Million by the following Product Segments: Active ... The report provides separate comprehensive analytics for the ...
Breaking Medicine Technology:Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020 2Global Market Report of Pralmorelin 2Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21
... Dec. 29, 2010 Reportlinker.com announces that a ... catalogue: The Market for Pharmaceuticals ... http://www.reportlinker.com/p0203101/The-Market-for-Pharmaceuticals-in-Brazil-Russia-India--China.html Evaluate the ... Brazil, Russia, India and China now and in ...
... Dec. 29, 2010 Centocor Ortho Biotech Inc. announced ... Application (sBLA) with the U.S. Food and Drug Administration ... treatment of moderately to severely active ulcerative colitis (UC) ... to conventional therapy.  REMICADE was designated orphan drug status ...
Cached Medicine Technology:Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China 2Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China 3Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China 4Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China 5Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication 2Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication 3Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication 4Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication 5Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication 6
Inquire...
Inquire...
Contour I pouches are light as a feather and feature our tapered SoftFlex skin barrier for comformability, flexbility and comfort. All Contour I pouches have ComfortWear panels that keep skin cool an...
Inquire...
Medicine Products: